Literature DB >> 19106401

Long-term outcome of Kawasaki disease.

Hideaki Senzaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19106401     DOI： 10.1161/CIRCULATIONAHA.107.749515

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  34 in total

1.  Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.

Authors:  Shuang Chen; Youngho Lee; Timothy R Crother; Michael Fishbein; Wenxuan Zhang; Atilla Yilmaz; Kenichi Shimada; Danica J Schulte; Thomas J A Lehman; Prediman K Shah; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

2.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

3.  Evaluation of left ventricular systolic strain in children with Kawasaki disease.

Authors:  Qiu-Qin Xu; Yue-Yue Ding; Hai-Tao Lv; Wan-Ping Zhou; Ling Sun; Jie Huang; Wen-Hua Yan
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

Review 4.  Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.

Authors:  Seyyedeh Saneeymehri; Katherine Baker; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

5.  Calcium scoring in patients with a history of Kawasaki disease.

Authors:  Andrew M Kahn; Matthew J Budoff; Lori B Daniels; Susan Jimenez-Fernandez; Amber S Cox; John B Gordon; Jane C Burns
Journal:  JACC Cardiovasc Imaging       Date:  2012-03

6.  Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease.

Authors:  Youngho Lee; Danica J Schulte; Kenichi Shimada; Shuang Chen; Timothy R Crother; Norika Chiba; Michael C Fishbein; Thomas J A Lehman; Moshe Arditi
Journal:  Circulation       Date:  2012-02-23       Impact factor: 29.690

7.  Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.

Authors:  Miyu Tajima; Yusuke Shiozawa; Jiro Kagawa
Journal:  Pediatr Cardiol       Date:  2015-03-10       Impact factor: 1.655

8.  Two cases of new coronary aneurysms that developed in the late period after Kawasaki disease.

Authors:  Junichi Ozawa; Hiroshi Suzuki; Satoshi Hasegawa; Fujito Numano; Hisanori Haniu; Kenichi Watanabe; Makoto Uchiyama; Akihiko Saitoh
Journal:  Pediatr Cardiol       Date:  2012-10-09       Impact factor: 1.655

Review 9.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

Review 10.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.